BANK OF AMERICA CORP /DE/
BankPosition in ABOS — Acumen Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in ABOS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$733,664
-$22,045 QoQ
Shares Held
274,781
-14.2% QoQ
Ownership
0.380%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 96 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ABOS ranks #228 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ABOS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $733,664 | 274,781 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $755,709 | 320,216 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $506,719 | 240,152 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $365,475 | 213,729 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $170,529 | 147,009 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $174,826 | 158,934 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $255,707 | 148,668 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $344,034 | 138,724 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $296,993 | 122,725 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $326,493 | 80,616 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $400,775 | 104,369 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $68,370 | 16,475 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $75,722 | 15,743 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $113,049 | 27,845 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $208,514 | 38,614 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $226,406 | 22,573 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $132,191 | 28,126 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $101,874 | 26,055 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $142,601 | 21,095 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $14,710 | 990 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||